The (pro)renin receptor: therapeutic consequences

Bibliography

• DANSER AHJ: Local renin-angiotensin systems: the unanswered questions. Int. J. Biochem. Cell Biol. (2003) 35:759-768.
   Web of Science ®Google Scholar
• VAN KATS JP, SCHALEKAMP MADH, VERDOUW PD et al.: Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int. (2001) 60:2311-2317.
   PubMed Web of Science ®Google Scholar
• VAN KATS JP, CHAI W, DUNCKER DJ et al.: Adrenal angiotensin. Origin and site of generation. Am. J. Hypertens. (2005) 18:1045-1051.
   Google Scholar
• CAMPBELL DJ, KLADIS A, DUNCAN AM: Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension (1993) 22:513-522.
   PubMed Web of Science ®Google Scholar
• KLOTZ S, FORONJY RF, DICKSTEIN ML et al.: Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation (2005) 112:364-374.
   PubMed Web of Science ®Google Scholar
• VAN KATS JP, DANSER AHJ, VAN MEEGEN JR et al.: Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation (1998) 98:73-81.
   PubMedGoogle Scholar
• VAN ESCH JH, TOM B, DIVE V et al.: Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. Hypertension (2005) 45:120-125.
   PubMed Web of Science ®Google Scholar
• BATENBURG WW, GARRELDS IM, BERNASCONI CC et al.: Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation (2004) 109:2296-2301.
   PubMed Web of Science ®Google Scholar
• TOM B, GARRELDS IM, SCALBERT E et al.: ACE- versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency? Arterioscler. Thromb. Vasc. Biol. (2003) 23:251-256.
   Google Scholar
• DANSER AHJ, VAN KATS JP, ADMIRAAL PJJ et al.: Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension (1994) 24:37-48.
   PubMed Web of Science ®Google Scholar
• DANSER AHJ, VAN KESTEREN CAM, BAX WA et al.: Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding. Circulation (1997) 96:220-226.
   PubMedGoogle Scholar
• DANSER AHJ, DERKX FHM, SCHALEKAMP MADH et al.: Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J. Hypertens. (1998) 16:853-862.
   Google Scholar
• KANTACHUVESIRI S, FLEMING S, PETERS J et al.: Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J. Biol. Chem. (2001) 276:36727-36733.
   Google Scholar
• PRESCOTT G, SILVERSIDES DW, REUDELHUBER TL: Tissue activity of circulating prorenin. Am. J. Hypertens. (2002) 15:280-5.
   Web of Science ®Google Scholar
• VÉNIANT M, MÉNARD J, BRUNEVAL P et al.: Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J. Clin. Invest. (1996) 98:1966-1970.
   Google Scholar
• NGUYEN G, DELARUE F, BURCKLÉ C et al.: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. (2002) 109:1417-1427.
   Google Scholar
• LOUDON M, BING RF, THURSTON H, SWALES JD: Arterial wall uptake of renal renin and blood pressure control. Hypertension (1983) 5:629-634.
   PubMed Web of Science ®Google Scholar
• MARU I, OHTA Y, MURATA K, TSUKADA Y: Molecular cloning and identification of N-acyl-D-glucosamine 2-epimerase from porcine kidney as a renin-binding protein. J. Biol. Chem. (1996) 271:16294-16299.
   Google Scholar
• VAN KESTEREN CAM, DANSER AHJ, DERKX FHM et al.: Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension (1997) 30:1389-1396.
   PubMed Web of Science ®Google Scholar
• SARIS JJ, DERKX FHM, DE BRUIN RJA et al.: High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am. J. Physiol. (2001) 280:H1706-H1715.
   Google Scholar
• VAN DEN EIJNDEN MMED, SARIS JJ, DE BRUIN RJA et al.: Prorenin accumulation and activation in human endothelial cells. Importance of mannose 6-phosphate receptors. Arterioscler. Thromb. Vasc. Biol. (2001) 21:911-916.
   Google Scholar
• SCHMITZ C, GOTTHARDT M, HINDERLICH S et al.: Normal blood pressure and plasma renin activity in mice lacking the renin-binding protein, a cellular renin inhibitor. J. Biol. Chem. (2000) 275:15357-15362.
   Google Scholar
• SARIS JJ, VAN DEN EIJNDEN MMED, LAMERS JMJ et al.: Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II. Hypertension (2002) 39:573-537.
   PubMed Web of Science ®Google Scholar
• DANSER AHJ, DEINUM J: Renin, prorenin and the putative (pro)renin receptor. Hypertension (2005) 46(5):1069-1076.
   PubMed Web of Science ®Google Scholar
• LUDWIG J, KERSCHER S, BRANDT U et al.: Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J. Biol. Chem. (1998) 273:10939-10947.
   Google Scholar
• L’HUILLIER N, SHARP MGF, DUNBAR DR, MULLINS JJ: On the relationship between the renin receptor and the vacuolar proton ATPase membrane sector-associated protein (M8.9). The local cardiac rennin–angiotensin–aldosterone system. Series: Basic Sciences for the Cardiologist, Frohlich ED, Re RN (Eds), Springer, New York, USA (2006) 20:17-34.
   Google Scholar
• AMSTERDAM A, NISSEN RM, SUN Z et al.: Identification of 315 genes essential for early zebrafish development. Proc. Natl. Acad. Sci. USA (2004) 101:12792-12797.
   Google Scholar
• ICHIHARA A, HAYASHI M, KANESHIRO Y et al.: Inhibition of diabetic nephropathy by a decoy peptide corresponding to the ‘handle’ region for nonproteolytic activation of prorenin. J. Clin. Invest. (2004) 114:1128-1135.
   Google Scholar
• ICHIHARA A, KANESHIRO Y, TAKEMITSU T et al.: Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension (2006) 47:894-900.
   PubMed Web of Science ®Google Scholar
• ICHIHARA A, SUZUKI F, NAKAGAWA T et al.: Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J. Am. Soc. Nephrol. (2006) 17:1950-1961.
   Google Scholar
• VAN ESCH JHM, SCHUIJT MP, SAYED J et al.: AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation. Br. J. Pharmacol. (2006) 148:452-458.
   Web of Science ®Google Scholar
• HUANG Y, WONGAMORNTHAM S, KASTING J et al.: Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. (2006) 69:105-113.
   PubMed Web of Science ®Google Scholar
• SARIS JJ, T’HOEN PAC, GARRELDS IM et al.: Prorenin induces intracellular signalling in cardiomyocytes independently of angiotensin II. Hypertension (2006) (In Press).
   PubMedGoogle Scholar
• BURRIDGE K, WENNERBERG K: Rho and Rac take center stage. Cell (2004) 116:167-179.
   PubMed Web of Science ®Google Scholar
• BURCKLÉ CA, DANSER AHJ, MÜLLER DN et al.: Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension (2006) 47:552-556.
   PubMed Web of Science ®Google Scholar
• KANESHIRO Y, ICHIHARA A, TAKEMITSU T et al.: Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int. (2006) 70(4):641-646.
   PubMed Web of Science ®Google Scholar
• ZHENG M, HOU R, XIAO RP: Acidosis-induced p38 MAPK activation and its implication in regulation of cardiac contractility. Acta Pharmacol. Sin. (2004) 25:1299-1305.
   Google Scholar
• KAN H, BIRKLE D, JAIN AC et al.: p38 MAP kinase inhibitor reverses stress-induced cardiac myocyte dysfunction. J. Appl. Physiol. (2005) 98:77-82.
   Google Scholar
• VAN KESTEREN CAM, SARIS JJ, DEKKERS DHW et al.: Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II. Cardiovasc. Res. (1999) 43:148-156.
   PubMed Web of Science ®Google Scholar
• LUETSCHER JA, KRAEMER FB, WILSON DM et al.: Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N. Engl. J. Med. (1985) 312:1412-1417.
   Google Scholar